profit from every $100 of sales.
$0$100
Fractyl Health
$0.90+11.27% today
-19.3% in 1 year
1-year low $0.391-year high $11.45
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2023 to 2024.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
It holds more cash than debt.
No debt5 years
Money in, money out
What Fractyl Health sold, what it kept, and what it did with the cash.
Sales went from $0 in 2022 to $0 in 2025, with -$141 million of profit last year.
SalesProfit
Fractyl Health vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Fractyl Health | No profit yet | ||
 Vertex Pharmaceuticals | 34.5× · Expensive | ||
 Regeneron Pharmaceuticals | 21.9× · Fair price | ||
 Moderna | No profit yet | ||
 CSL | 22.0× · Fair price |
AI analysis
An AI analyst reads Fractyl Health's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 0 | 0 | 0 | 0 | |
| 0 | 0 | 0 | 0 | |
| -49 | -51 | -94 | -97 | |
| -49 | -51 | -93 | -96 | |
| -46 | -77 | -69 | -141 | |
| -1.34 | -1.98 | -1.62 | -0.92 | |
| – | 35.8% | 46.2% | – | |
| – | -42,363.3% | -100,571.0% | – | |
| – | -64,242.5% | -73,864.5% | – |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 61 | 76 | 108 | 121 |
| Cash | 49 | 33 | 67 | 82 |
| Total debt | 19 | 86 | 63 | 62 |
| Total liabilities | 313 | 401 | 80 | 112 |
| -252 | -325 | 28 | 9 | |
| 82 | 48 | 44 | 153 | |
| – | – | -81.3% | -107.6% | |
| 18.4% | 23.7% | -241.7% | -1,490.3% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -46 | -43 | -66 | -90 | |
| 0 | 0 | 2 | 1 | |
| -46 | -43 | -67 | -91 | |
| Dividends paid | – | – | – | – |
| – | – | – | – | |
| 3 | 4 | 14 | 7 |
Valuation
- –
- –
- –
- 6.1×
- 128.9×
- –
- –
- -561.4%
- -573.1%
- 0.0%
Profitability
- 46.2%
- -100,571.0%
- -73,864.5%
- 0.0%
- -89.5%
- -111.6%
- 10,146.1%
- -116.1%
- -93.9%
- –
Growth
- −22.5%
- –
- −35.1%
- –
- +12.3%
Financial health
- -0.1×
- 6.52
- 50.8%
- –
- 4.78
- 4.78
- 0.00
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 1%of 952
Bottom 4%of 888
What analysts expect
- Average price target
- $5.00
- Range
- $2.00 – $8.00
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 12, 2026 | -0.13 | -0.17 | +23.5% |
| Mar 24, 2026 | 0.15 | -0.19 | +178.9% |
| Nov 12, 2025 | -0.35 | -0.34 | −2.9% |
| Aug 12, 2025 | -0.53 | -0.37 | −43.2% |
| May 13, 2025 | -0.49 | -0.49 | +0.0% |
| Mar 3, 2025 | -0.52 | -0.44 | −18.2% |
| Nov 12, 2024 | -0.48 | -0.50 | +4.0% |
| Aug 14, 2024 | -0.36 | -0.46 | +21.7% |
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/7Passes 0 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
36No pass
Benjamin Graham
21No pass
Philip Fisher
39No pass
Peter Lynch
0No pass
Joel Greenblatt
0No pass
Charlie Munger
35No pass
Terry Smith
32No pass
Questions about Fractyl Health
Is Fractyl Health a good stock to buy?
A business with weak numbers that is not profitable yet. 0 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Fractyl Health AI analysis
What does Fractyl Health do?
Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. It is in Biotechnology.
Does Fractyl Health pay a dividend?
No. Fractyl Health does not pay a dividend at the moment.
Is Fractyl Health stock halal?
No. Fractyl Health does not pass our halal screen: its debt is 514% of its market value, at or above the 33% limit. How we check
How has Fractyl Health stock done over the past year?
Down 19.3% over the past twelve months, to $0.90. It traded between $0.39 and $11.45 and is 92.1% below its high.
Who are Fractyl Health's competitors?
The largest listed companies in the same industry are Vertex Pharmaceuticals, Regeneron Pharmaceuticals, Moderna and CSL. The peers table on this page compares their profit, growth and price with Fractyl Health's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.